Short NRSN - IPO Lockup Expires 6/7/2022 Penjualan

NeuroSense Therapeutics Ltd.NASDAQ

Deskripsi

⋅ 26 Mei 2022 pukul 19.03

Little to no news, increasing net revenue losses year-over-year and tremendously spike in short-interest, now would be a good time to short.

Between the earnings call and expiring IPO lockup, NRSN leaning towards a dramatic drop.

Trend Analysis

Lebih lanjut